One hundred and seventy-seven former heroin addicts, consisting of 85 who were newly admitted to a methadone maintenance program and 92 who had received methadone for a mean period of 30 months, were prospectively studied for up to 2 years in order to determine: (1) the effect of heroin withdrawal on the hepatic abnormalities, and (2) the incidence of HBsAg, anti-HBs, and anti-HCc as indices of the frequency of hepatitis B virus infection. Our study indicates that (1) hepatic abnormalities persist when heroin is discontinued and are not temporally related to drug and/or needle usage, and (2) that 71% of subjects had either HBsAg or anti-HBs; anti-HBc was tested for in 16 patients and was present in 100o, although 9 of the 16 were both HBsAg-and anti-HBs-negative. This study suggests that hepatitis B is largely responsible for the liver dysfunction. It is proposed that an abnormality in immune function, induced by heroin, is responsible for the high incidence of chronic hepatitis. Attention is drawn to the similarity between former drug addicts and hemophiliacs, since both develop chronic hepatitis in spite of anti-HBs in the serum.
INTRODUCTION
Abnormal liver function tests have been found in up to 83% of asymptomatic drug addicts entering a detoxification program [1, 2] . The cause of these abnormalities has not been determined, although a direct toxic effect of the drug [3] , contamination of the drug with other toxic agents [4] , concomitant use of alcohol [ 1] and viral hepatitis [5, 6] have all been suggested etiologies. Although most studies [2, 7] have shown a low incidence of HBs-antigenemia in these patients, recent studies employing sensitive assays for both HBsAg and anti-HBs [2, 8] have shown a high incidence of prior infection with hepatitis B virus (HBV).
In view of the uncertainty regarding the etiology of hepatitis in drug users, the present study was designed to assess: (1) the effect of heroin withdrawal on the hepatic abnormalities, since their persistence would exclude a lesion temporally related to injection of the drug and/ or contaminants, and (2) the prevalence of HBV infection as determined by the incidence of HBsAg, anti-HBs, and anti-HBc.
MATERIALS AND METHODS

Patients
Two groups of patients were studied. Eighty-five patients were newly admitted to a methadone program and had not received methadone prior to the study (Group A). Ninety-two patients (Group B) had received methadone for periods of 2 months to 6 years (mean duration of 30 months) before the study. None of the patients showed evidence of alcoholic liver disease. Twenty percent had intakes of alcohol which varied between 3 and 6 ounces daily. None admitted to an intake of alcohol in excess of 6 ounces. The dosage of methadone was similar in both groups (mean 35 mg/ day). The ages of the patients ranged from 21 to 59 years, mean 29 years. Methods Serum GOT, alkaline phosphatase, and bilirubin were measured on entry to the study and were followed serially at intervals of On initial testing, SGOT elevations were found in 65% of newly admitted patients and in 76% of patients already maintained on methadone. The abnormalities were minor, and the mean value for newly admitted patients was the same as that for patients already on therapy ( Table 1) . Two of the newly admitted patients had acute viral hepatitis on entry to the study and were excluded from the group analysis. There was no significant difference between serum alkaline phosphatase and bilirubin levels for the two groups of patients (Table 1) . 
DISCUSSION
This study confirms the previously reported high incidence of SGOT abnormalities in a randomly selected population of as'ymptomatic drug users. Furthermore, the frequency with which initially normal SGOT levels became abnormal suggests that the incidence of SGOT abnormalities may approach 100% if samples are tested with sufficient scatter in time. The persistence of the SGOT abnormalities after 2 years of follow-up, in some cases after 7 years of heroin abstinence, is in keeping with the observations of others [9, 10] , but in contrast to the findings in one study [11] , although the authors of that study point out shown to be a more sensitive indicator of HBV infection than the other serological markers [15] and it has been suggested that it correlates well with viral replication in the hepatocyte. The presence of anti-HBc in these patients thus may indicate that viral replication is occurring in the liver cells. This provides further evidence that the HBV is responsible for the liver disease in these patients. If, indeed, the hepatic abnormalities are related to HBV infection, the frequency of unresolved hepatitis after this infection would be 7 to 8 times greater than the incidence in the general population, where it is estimated at 10% [16] . Furthermore, it is unusual to lose HBsAg and then develop chronic hepatitis; Redeker [16] studied 429 patients with acute icteric type B hepatitis and found that all the patients who developed chronic hepatitis remained HBsAg-positive. In no instance was the loss of HBsAg followed by chronic hepatitis. The situation in the drug addict is clearly different and may be similar to the situation in hemophiliacs, where chronic hepatitis has been described, despite clearance of HBsAg and the presence in the serum of anti-HBs [17] . It is thus possible that former drug addicts and hemophiliacs represent a unique population, in that they develop chronic hepatitis despite the presence of excess anti-HBs, long considered a protective or neutralizing antibody. This may be related to the fact that both groups are exposed to frequent transfusions, with the possible risk of constant re-infection. Naturally, this risk is more significant in the drug addicts, but even hemophiliacs could be exposed, since blood containing anti-HBc, in the absence of HBsAg, has been shown to be infectious [18] . Routine blood screening would thus not detect viral particles. The possibility of non-A, non-B hepatitis is a real one, particularly in view of its parenteral transmissibility and potential for causing chronic hepatitis, but in the absence of a serological marker, this remains pure conjecture. A second explanation for this anomaly, of persistent hepatitis in drug addicts, could be related to altered immune regulation. It is well established that heroin addicts have an abnormally high incidence of auto-antibodies, false positive syphilis serology, and hyperglobulinemia [19, 20] ; in addition, T cell function has been shown to be impaired [21] . We have studied suppressor T cell function in heroin addicts and have shown a defect when assessed by conconavalin A blast formation [22] . It may then be proposed that, during active heroin use, effector T cell function is impaired (as shown by Brown et al. [21] ), resulting in incomplete clearance of virus antigen from the liver. A suppressor T cell defect allows for inappropriately high levels of immunoglobulin and auto-antibody production. With withdrawal of the heroin, the suppressor T cell defect abates, allowing for normal immunoregulation, with gradual reduction in the levels of immunoglobulin and auto-antibodies, as has been observed when heroin addicts stop their drug abuse [23] . It is conceivable that the abnormalities in immune function described in heroin addicts are unrelated to the persistence of the hepatitis and that this persistence is merely a result of continuous, low-dose infection by HBV. However, there is mounting evidence that the nature of the immune response is all-important in the pathogenesis of the liver injury associated with HBV infection [24, 25] , especially since the HBV appears not to be a cytopathic virus in its own right [26, 27] .
It is thus apparent that the nature of the hepatitis in former drug addicts is a complex one; the lesion is chronic, persisting for years after discontinuance of heroin, and appears to be related to HBV infection. There appears to be a similarity between the immunological behavior, in terms of hepatitis serology, between hemophiliacs and former drug addicts, a similarity which was not previously mentioned. It is possible that study and comparison of the immune response in these two groups, dissimilar as they may be in this respect, will result in better understanding of the nature and mechanisms of chronic (unresolved) hepatitis, type B.
